Medicine for treating acute leukemia

Abstract

The invention discloses a medicine for treating acute leukemia. The medicine, as a traditional Chinese medicinal agent, is characterized by being prepared from the following twelve traditional Chinese medicines: cornu bubali, pseudobulbus cremastrae seu pleiones, spreading hedyotis herb, herba scutellariae barbatae, radix arnebiae seu lithospermi, rhizoma curcumae, indigo naturalis powder, radix rehmanniae recen, radix paeoniae rubra, radix astragali, radix scrophulariae and turtle shell; and the proportions of the various traditional Chinese medicines in parts by weight are as follows: 25-35 parts of the cornu bubali, 17-23 parts of the pseudobulbus cremastrae seu pleiones, 17-23 parts of the spreading hedyotis herb, 17-23 parts of the herba scutellariae barbatae, 17-23 parts of the radix arnebiae seu lithospermi, 8-12 parts of the rhizoma curcumae, 8-12 parts of the indigo naturalis powder, 17-23 parts of the radix rehmanniae recen, 17-23 parts of the radix paeoniae rubra, 17-23 parts of the radix astragali, 17-23 parts of the radix scrophulariae and 17-23 parts of the turtle shell. The medicine disclosed by the invention has the characteristics of being relatively good in treatment effect, short in treatment course, not easy for recurrence, free from toxic and side effects and relatively low in treatment expense. Upon clinical verification, the medicine disclosed by the invention is relatively good in functions of clearing away heat and toxic materials, promoting blood circulation and removing blood stasis, and the medicine has a curative effect on attacking pathogen and strengthening healthy energy; and compared with an existing medicine, the medicine disclosed by the invention not only has the characteristics of being relatively good in treatment effect and short in treatment course, but also has the advantages of being free from toxic and side effects and low in treatment expense.

Description

technical field [0001] The invention relates to a medicine for treating acute leukemia and belongs to the technical field of medicines for treating leukemia. Background technique: [0002] Leukemia is a malignant proliferative disease of hematopoietic tissue, which is characterized by abnormal diffuse proliferation of some white blood cells and their precursor cells in bone marrow or other hematopoietic tissues, and can moisten other tissues. Especially acute leukemia, acute patients have a sudden onset, fever, anemia, hemorrhage, enlargement of liver and spleen and lymph nodes, the condition is dangerous, and it is called blood cancer. At present, most of the drugs used to treat this type of acute leukemia are western medicines, and few traditional Chinese medicines are used. Although these western medicines have certain curative effects, their side effects are also relatively serious, and patients are prone to drug dependence; and the treatment course of western medicines ...

AI Technical Summary

Problems solved by technology

At present, most of the drugs used to treat this type of acute leukemia are western medicines, and few traditional Chinese medicines are used. Although these western medicines have certain curative effects, their side effects are also relatively serious, and patients are prone to drug dependence; and the treatment course of western medicines is relatively long , the effect is slow, in addition, the existing western medicine generally has the problem of high treatment cost and unsatisfactory curative effect

Therefore, the effect of existing drugs for the treatment of acute leukemia is still not ideal.